Literature DB >> 4031558

Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.

A J Tingle, J K Chantler, K H Pot, D W Paty, D K Ford.   

Abstract

Six women developed chronic long-term arthropathy after postpartum immunization against rubella. All individuals developed acute polyarticular arthritis within 12 days to three weeks postimmunization and have had continuing chronic or recurrent arthralgia or arthritis for two to seven years after vaccination. Acute neurological manifestations, consisting of carpal tunnel syndrome or multiple paresthesiae, developed postvaccination in three women. Two have developed continuing active or chronic recurrent episodes of blurred vision, paresthesiae, and painful limb syndromes together with recurrent joint symptoms. Chronic rubella viremia has been detected in peripheral blood mononuclear cell (MNC) populations in five of the six women up to six years after vaccination. In addition rubella virus was isolated from breast milk MNCs in one individual at nine months postvaccination and from peripheral blood MNCs in two of four breast-fed infants studied at 12-18 months of age. Immune responses to rubella virus studied at sequential intervals after vaccination correlated with development of rheumatologic and neurological manifestations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031558     DOI: 10.1093/infdis/152.3.606

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Effect of antiviral antibody on maintenance of long-term rubella virus persistent infection in Vero cells.

Authors:  E S Abernathy; C Y Wang; T K Frey
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays.

Authors:  T Zhang; C A Mauracher; L A Mitchell; A J Tingle
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

4.  Joint California Department of Health Services-California Medical Association campaign to eliminate congenital rubella syndrome.

Authors:  L Dales; K W Kizer; G V Elliott
Journal:  West J Med       Date:  1988-03

5.  Detection of rubella virus gene sequences by enzymatic amplification and direct sequencing of amplified DNA.

Authors:  F A Eggerding; J Peters; R K Lee; C B Inderlied
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

6.  Rubella in Guipuzcoa (Basque Country, Spain) a four-year serosurvey.

Authors:  E Pérez Trallero; G Cilla Eguiluz; M Dorronsoro Iraeta; J R Saenz Dominguez
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

7.  Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.

Authors:  L A Mitchell; M K Ho; J E Rogers; A J Tingle; R G Marusyk; J M Weber; P Duclos; M L Tepper; M Lacroix; M Zrein
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

8.  Autoantigens interact with cis-acting elements of rubella virus RNA.

Authors:  G P Pogue; J Hofmann; R Duncan; J M Best; J Etherington; R D Sontheimer; H L Nakhasi
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Congenital rubella syndrome after rubella vaccination in 1-4 weeks periconceptional period.

Authors:  R Nasiri; J Yoseffi; M Khajedaloe; M Sarafraz Yazdi; F Delgoshaei
Journal:  Indian J Pediatr       Date:  2009-04-06       Impact factor: 1.967

10.  Immune responses to wild and vaccine rubella viruses after rubella vaccination.

Authors:  M G Cusi; R Metelli; P E Valensin
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.